⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

SYRE

Spyre Therapeutics, Inc.

Healthcare · Biotechnology

90.33USD

-2.0000 (-2.17%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on SYRE.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 90.33
P/E—
Dvd Ind Yld0.0%
P/B7.67
P/S—
Curr EV/T12M EBITDA—
Mkt Cap (USD)8.4B
Curr EV (USD)7.0B
2)

Per Share Data

EPS T12M0.88
DPS—
Bk Val Per Sh10.84
Rev/Sh0.00
Cash/Sh12.99
Curr Shares Out93.5M
FCF/Sh-1.67
3)

Cash Flow Analysis

P/CF-40.4
Curr P/FCF-99.4
CF/NI1.2
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales—
Eff Interest Rate—
4)

Growth Potential

Dil EPS 1Y Gr210.7%
Cap 1Y Gr38.1%
BPS 1Y Gr257.6%
R&D To Sales—
Retention Rate—
Rev 1Y Gr—
FCF 1Y Gr-57.6%
Assets 1Y Gr27.8%
5)

Profitability

EBITDA-0.2B
EBIT-0.2B
Operating Margin0.0%
Pretax Margin—
Net Margin0.0%
ROA-20.9%
ROE-23.0%
ROC-18.3%
Asset Turnover0.00
6)

Structure

Current Ratio18.53
Quick Ratio18.23
Debt/Assets0.0%
Debt/Com Eq0.0%
Net Debt/EBITDA0.78
Tot Debt/Capital0.0%
Gross Margin0.0%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.